EQT trades 19.6% below analyst target despite UBS cut
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
UBS analyst Josh Silverstein cut EQT Corp.'s price target to $75.00 from $76.00 while keeping a Buy rating, citing near-term dilution from the company's acquisition of RRC. UBS still sees long-term value in the deal through better inventory quality, lower costs and a stronger balance sheet, and notes EQT's progress on debt reduction.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.